The Formula Group
Contact Us  |  Site Map  |  Search
Company Profile  |  Solutions  |  Business Units  |  Investor Relations  |  News  |  Community Activities
News News
Press Releases
Press Releases


Sapiens Announces Q4 2003 and Year-End Results

The Company Reports a Profit for the Second Consecutive Quarter Annual Results Show Improved Net Results Despite a Decline In Revenues

Monday February 9, 7:36 am ET

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)- Feb. 9, 2004--Sapiens International Corporation (Nasdaq:SPNS - News and TASE:SPNS), and (TASE:SPNS) today announced its unaudited results of operations for the year ended December 31, 2003 and its unaudited results of operations for the fourth quarter of 2003.

Q4 2003 Results:
Compared to the previous quarter of 2003, the Company reported marginal but continuing improvement in the fourth quarter of 2003. Revenues increased slightly from $13.4 million to $13.5 million while gross profit increased 4.5% from $6.4 million to $6.7 million and the gross profit margin improved 4.0% from 47.7% to 49.6%. The Company reported operating income of $0.5 million in the fourth quarter of 2003 compared with operating income of $0.3 million in the previous quarter, and net income of $0.15 million compared with net income of $0.04 million in the previous quarter.

Compared to the fourth quarter last year, revenues in the fourth quarter of 2003 decreased to $13.5 million from $15.9 million. Gross profit margin rose to 49.6% compared to 42.7% in the same period last year. Operating income amounted to $0.5 million compared with an operating loss of $2.4 million in the same period of last year. The Company recorded net income of $0.15 million compared with a net loss of $4.9 million in the same period of last year.

2003 Annual results:
Total revenues for 2003 decreased to $52.3 million in 2003 from $64.8 million in 2002. The Company's gross profit margin increased to 45.3% compared with 44.3% in 2002, reflecting continued overall improvement in revenue mix, project delivery and utilization of resources. The operating loss decreased to $1.5 million from $1.6 million last year, and the net loss decreased to $2.2 million compared with a net loss of $5.2 million last year.

Itzick Sharir, President and Chief Executive Officer of Sapiens, commented: "2003 was a tough year for Sapiens and I am pleased that we have come out stronger and better prepared for the road ahead.

"The fourth quarter is our second consecutive profitable quarter with an improvement of 65% in operating income compared with the previous quarter. Year over year, we have succeeded in significantly reducing our net loss by 58% ($2.2 million compared with $5.2 million) despite a sharp decline in revenues, primarily as part of the Company's decision to abandon non-strategic lines of business. We have improved our cash position and liquidity, $31.8 million compared with $22 million, due primarily to a successful offering of convertible debentures on the Tel Aviv Stock Exchange, resulting in gross proceeds to the Company of approximately $17 million in the fourth quarter.

"Entering 2004, we continue with our strategic plan in servicing the insurance market. We are launching new solutions under our INSIGHT suite of products while strengthening our working relations with strategic partners at all levels, primarily IBM Corporation."

Q4 2003 CONFERENCE CALL:
Sapiens International will hold a Conference Call to discuss the results on Monday, February 9, 2004, at 09:00AM (EST)

To participate, please call:
From the US and Canada: 1-866-485 2399
From the UK: 0-800-917 4613
International callers: + 972-3-9180610
10 minutes prior to start time

About Sapiens
Sapiens International Corporation (Nasdaq and TASE:SPNS), a member of the Formula Group of companies, is a leading global provider of proven IT solutions that modernize business processes and enable insurance organizations to adapt quickly to change. Sapiens' innovative solutions are widely recognized for their ability to cost-effectively align IT with the business demands for speed, flexibility and efficiency. Sapiens operates through its subsidiaries in North America, United Kingdom, EMEA and Asia Pacific and has partnerships with market leaders such as IBM and EDS. Sapiens' clients include Allianz Group, AXA, Liverpool Victoria, Menora, Norwich Union, OneBeacon, Principal Financial, Prudential, Abbey National, ING, Occidental Fire & Casualty, among others.

For more information, please visit http://www.sapiens.com.

Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of the company's accounting policies and other risk factors detailed in the Company's SEC filings.

 

                SAPIENS INTERNATIONAL CORPORATION N.V.
              Condensed Consolidated Statements of Income
         (U.S. Dollars in thousands, except per share amounts)



                 For the three months ended     For the year ended
                 --------------------------- -------------------------
                   12/31/2003   12/31/2002    12/31/2003   12/31/2002
                 -------------  ------------ -----------  ------------
                  (Unaudited)   (Unaudited)  (Unaudited)  (Unaudited)
Revenues
Products           $     9,082  $    10,144  $    32,673  $    42,008
Consulting and
 other services          4,392        5,761       19,645       22,820
                    -----------  -----------  -----------  -----------
Total revenues          13,474       15,905       52,318       64,828
                    -----------  -----------  -----------  -----------

Cost of revenues
Products                 4,389        5,774       17,489       22,567
Consulting and
 other services          2,403        3,333       11,118       13,543
                    -----------  -----------  -----------  -----------
Total cost of
 revenues                6,792        9,107       28,607       36,110
                    -----------  -----------  -----------  -----------

Gross Profit             6,682        6,798       23,711       28,718

Expenses
Research and
 development, net          727        1,630        3,656        6,017
Selling, general
 and administrative      5,414        7,075       21,539       23,782
Restructuring expenses       -          481            -          481
                    -----------  -----------  -----------  -----------

Operating Income/(Loss)    541       (2,388)      (1,484)      (1,562)

Financial
 expenses, net             357          239          958          971
Taxes and other
 expenses, net (a)          39        2,234         (255)       2,620
                    -----------  -----------  -----------  -----------

Net Income/(Loss)  $       145  $    (4,861) $    (2,187) $    (5,153)
                    ===========  ===========  ===========  ===========

Basic and diluted
 earnings/(loss)
 per share (b)     $      0.01  $     (0.60) $     (0.20) $     (0.69)
                    ===========  ===========  ===========  ===========

Weighted average
 shares used to
 compute:
Basic earnings/(loss)
 per share              10,694        8,104       10,692        7,474
Diluted earnings/(loss)
 per share (b)          17,358        8,104       10,692        7,474

Note      a: Includes minority interest
          b: Due to the net loss in 2003 and 2002 the inclusion of
             dilutive securities would be antidilutive.

                SAPIENS INTERNATIONAL CORPORATION N.V.
                 Condensed Consolidated Balance Sheets
                      (U.S. Dollars in thousands)


                                              12/31/2003   12/31/2002
                                              -----------  -----------
                                              (Unaudited)  (Unaudited)

Assets

  Cash                                       $    31,775  $    22,001
  Short-term investments                           1,039        1,652
                                              -----------  -----------
                                                  32,814       23,653
  Trade receivables                                9,133       10,405
  Other current assets                             4,798        5,842
                                              -----------  -----------
  Total current assets                            46,745       39,900
                                              -----------  -----------

  Property and equipment, net                      3,060        3,426
  Other assets                                    25,437       21,826
                                              -----------  -----------
Total assets                                 $    75,242  $    65,152
                                              ===========  ===========

Liabilities and shareholders' equity

  Short-term loans and current maturities
   of long-term debt                         $     9,579  $     9,483
  Trade payables                                   2,619        2,578
  Other liabilities and accrued expenses          11,054       14,541
  Deferred revenue                                 3,254        3,683
                                              -----------  -----------
  Total current liabilities                       26,506       30,285
                                              -----------  -----------

  Long-term debt and other liabilities             8,111        7,787
  Convertible debentures                          15,191            -
  Redeemable shares in a subsidiary               11,505       11,185
  Shareholders' equity                            13,929       15,895
                                              ------------ -----------
Total liabilities and shareholders' equity   $    75,242  $    65,152
                                              ===========  ===========

Contact:
Sapiens International
Yuval Hadari, +1-877-554-2426 or +972-8-938-2721
E-mail: yuval.h@sapiens.com
or
Rebecca Green
Padilla Speer Beardsley
Tel: +1-212-752-8338
e-Mail: rgreen@psbpr.com

 

back Top